These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28337726)

  • 41. Cost-effectiveness analysis of oxycodone with naloxone versus oxycodone alone for the management of moderate-to-severe pain in patients with opioid-induced constipation in Canada.
    Goeree R; Goeree J
    J Med Econ; 2016; 19(3):277-91. PubMed ID: 26535790
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients' Health State Utility.
    Lawson R; King F; Marsh K; Altincatal A; Cimen A
    Adv Ther; 2016 Aug; 33(8):1331-46. PubMed ID: 27342744
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opioid-Induced Constipation in Oncological Patients: New Strategies of Management.
    Mesía R; Virizuela Echaburu JA; Gómez J; Sauri T; Serrano G; Pujol E
    Curr Treat Options Oncol; 2019 Dec; 20(12):91. PubMed ID: 31853656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.
    Jamal MM; Adams AB; Jansen JP; Webster LR
    Am J Gastroenterol; 2015 May; 110(5):725-32. PubMed ID: 25916220
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnesium hydroxide versus macrogol/electrolytes in the prevention of opioid-induced constipation in incurable cancer patients: study protocol for an open-label, randomized controlled trial (the OMAMA study).
    Kistemaker KRJ; de Graeff A; Crul M; de Klerk G; van de Ven PM; van der Meulen MP; van Zuylen L; Steegers MAH
    BMC Palliat Care; 2023 Mar; 22(1):22. PubMed ID: 36915062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opioid-Related Constipation.
    Liu JJ; Brenner DM
    Gastroenterol Clin North Am; 2022 Mar; 51(1):107-121. PubMed ID: 35135657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opioid-Induced Constipation.
    Webster LR
    Pain Med; 2015 Oct; 16 Suppl 1():S16-21. PubMed ID: 26461071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Opioid-induced constipation in oncologic patient: a clinical case treated with naloxegol].
    Gallo P
    Recenti Prog Med; 2019 Mar; 110(3):6e-9e. PubMed ID: 30968858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Narcotic bowel syndrome and opioid-induced constipation.
    Szigethy E; Schwartz M; Drossman D
    Curr Gastroenterol Rep; 2014 Oct; 16(10):410. PubMed ID: 25183577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Naloxegol for the treatment of opioid-induced constipation.
    Tack J; Corsetti M
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):855-61. PubMed ID: 25220391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Naloxegol , a new drug for the treatment of opioid-induced constipation.
    Corsetti M; Tack J
    Expert Opin Pharmacother; 2015 Feb; 16(3):399-406. PubMed ID: 25496063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Naldemedine: First Global Approval.
    Markham A
    Drugs; 2017 May; 77(8):923-927. PubMed ID: 28466424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Naloxegol: A Review of Clinical Trials and Applications to Practice.
    Dume R; Shuman M
    Orthop Nurs; 2019; 38(3):209-211. PubMed ID: 31124873
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient and provider differences in the treatment of opioid-induced constipation: a qualitative study.
    Keller MS; Jusufagic A; Spiegel BMR
    BMC Gastroenterol; 2019 Nov; 19(1):182. PubMed ID: 31718543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Population Exposure-Response Modeling of Naloxegol in Patients With Noncancer-Related Pain and Opioid-Induced Constipation.
    Al-Huniti N; Nielsen JC; Hutmacher MM; Lappalainen J; Cantagallo K; Sostek M
    CPT Pharmacometrics Syst Pharmacol; 2016 Jul; 5(7):359-66. PubMed ID: 27435972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opioid-induced constipation: challenges and therapeutic opportunities.
    Camilleri M
    Am J Gastroenterol; 2011 May; 106(5):835-42; quiz 843. PubMed ID: 21343919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of naloxegol in patients with cancer pain suffering from opioid-induced constipation.
    Lemaire A; Pointreau Y; Narciso B; Piloquet FX; Braniste V; Sabaté JM
    Support Care Cancer; 2021 Dec; 29(12):7577-7586. PubMed ID: 34120247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Constipation in Cancer Patients - an Update of Clinical Evidence.
    Dzierżanowski T; Mercadante S
    Curr Treat Options Oncol; 2022 Jul; 23(7):936-950. PubMed ID: 35441979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Evolving Role of Long-Term Pharmacotherapy for Opioid-Induced Constipation in Patients Being Treated for Noncancer Pain.
    Bowers BL; Crannage AJ
    J Pharm Pract; 2019 Oct; 32(5):558-567. PubMed ID: 29207909
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Naloxegol for managing opioid-induced constipation.
    Shelton KN; Clements JN
    JAAPA; 2017 Sep; 30(9):51-53. PubMed ID: 28858018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.